You're contacting media contact of this press release

Title: Lead Chemist Markus of Biotech Group NA Commends Pura Peptides for Consistent Purity Transparency and Reliable Service

United States, 12th Nov 2025 — Biotech Group N.A. today shares a detailed professional assessment highlighting the reliability and quality of peptide supplier Pura Peptides. Following extensive independent and internal laboratory testing, lead chemist Markus recommends Pura Peptides as a trusted research peptide provider, citing consistent purity results, rigorous documentation, and dependable customer support.As researchers increasingly require high-purity compounds for metabolic and receptor-based studies, the credibility of peptide suppliers has never been more critical. In his evaluation, Markus focused on several widely researched peptides, including tizepatide, retatrutide, and semaglutide—compounds currently utilized in diverse laboratory settings for investigative and experimental applications.“Our lab conducted HPLC and mass spectrometry analysis on numerous samples sourced from Pura Peptides,” Markus noted. “Across all tests, we observed purity levels exceeding 99%. These results aligned precisely with the Certificates of Analysis included with each shipment, confirming the accuracy and consistency of their reporting.”Markus emphasizes that the integrity of chromatographic data is essential when selecting research material vendors. Some suppliers in the peptide market have been known to publish incomplete or questionable purity data, making verification difficult. In contrast, Pura Peptides demonstrated a clear commitment to scientific transparency, offering accessible third-party testing verification and well-documented synthesis quality standards.“Scientific research depends on reliability and reproducibility,” Markus explained. “Pura Peptides provides complete chromatograms and mass spec data that are straightforward, detailed, and technically sound. Their...

This press release is issued by King Newswire